Načítá se...
Immune requirements for protective Th17 recall responses to Mycobacterium tuberculosis challenge
Tuberculosis (TB) vaccine development has focused largely on targeting T helper type 1 (Th1) cells. However, despite inducing Th1 cells, the recombinant TB vaccine MVA85A failed to enhance protection against TB disease in humans. In recent years, Th17 cells have emerged as key players in vaccine-ind...
Uloženo v:
| Vydáno v: | Mucosal Immunol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4517980/ https://ncbi.nlm.nih.gov/pubmed/25627812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mi.2014.136 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|